ZMC-002
BCMA-positive multiple myeloma
Phase 1Active
Key Facts
About Zhongmou Therapeutics
Clinical-stage biotech developing next-generation engineered T cell therapies for hematological cancers and solid tumors.
View full company profileBCMA-positive multiple myeloma
Clinical-stage biotech developing next-generation engineered T cell therapies for hematological cancers and solid tumors.
View full company profile